PROJECT

Projects

Summary of Investment Information

Project Number

45116

Company Name

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.

Date SPI Disclosed

Nov 17, 2021

Country

Indonesia

Region

East Asia and the Pacific

Projected Board Date

Jan 28, 2022

Environmental Category

B - Limited

Status

Active

Last Updated Date

Oct 26, 2022

Department

Regional Industry - MAS Asia & Pac

Industry

other

Previous Events

Approved : May 20, 2022
Signed : Jun 27, 2022
Invested : Oct 24, 2022

Sector

other

Project Description

 Brightgene Bio-Medical Technology Co., Ltd. (“Brightgene” or the “Company”) is a leading Chinese pharmaceutical company that focuses on the research and manufacturing of high barrier generics, active pharmaceutical ingredients (“APIs”), and finished dosage forms (“FDFs”). The proposed IFC investment will support Brightgene’s expansion into Indonesia to meet the growing local demand in the country (the “Project”) 

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation